STYLAGE® LIPS PLUS BI-FLEX® with Lidocaine

Description

Name: STYLAGE® LIPS PLUS BI-FLEX® with Lidocaine
Manufacturer: Vivacy
Active Substance(s): CROSS-LINKED HYALURONIC ACID (HA), MANNITOL, LIDOCAINE
Strength: 18.5mg/ml HA, 0.3% Lidocaine
Package Content: 1 x 1ml Pre-Filled Syringes, 2 x 30 G ½ Needles

STYLAGE® LIPS PLUS BI-FLEX® with Lidocaine is a dedicated lip filler developed by Laboratories VIVACY in France and formulated with 20mg/mL cross-linked hyaluronic acid and 0.3% lidocaine. Designed specifically for lip enhancement, it combines IPN-Like Technology™ with the BI-FLEX® lip-specific rheological profile to support pronounced volume and precise definition in the sensitive lip treatment area. Supplied as 1 × 1mL prefilled syringe with 2 × 30G ½ needles, practitioners looking to buy STYLAGE® LIPS PLUS BI-FLEX® with Lidocaine online may contact Maylips support team for guidance.

• Strength: 20mg/mL HA | 0.3% Lidocaine
• Active Ingredient: Hyaluronic acid (cross-linked) 18.5mg/mL; Lidocaine 0.3%
• Dosage Form: Injectable gel — 1 × 1mL prefilled syringe + 2 × 30G ½ needles
• FDA Approval Date: STYLAGE® is NOT FDA-approved for U.S. use. The product carries CE marking for European Union markets only (CE certification for medical devices under the EU MDR).
• Molecular Type: Cross-linked hyaluronic acid (IPN-Like Technology™) with mannitol and lidocaine
• Intended Use: Lip augmentation and perioral volume restoration. For use by licensed aesthetic professionals only
• Brand: STYLAGE®
• Country of Origin: France
• Manufacturer: Laboratories VIVACY (Paris, France)

STYLAGE® LIPS PLUS BI-FLEX® with Lidocaine was formulated specifically for the lip treatment area, rather than adapting a general-purpose volumizing filler for lip use. Laboratories VIVACY engineered the gel to support both volume enhancement and precise vermillion border definition, matching the rheological characteristics suited to the dynamic movement of lip tissue.

Targeted Augmentation & Volumizing

The LIPS PLUS designation reflects an elevated hyaluronic acid concentration of 18.5mg/mL. This specific concentration serves patients with distinct aesthetic goals:

• Pronounced Augmentation: Ideal for individuals seeking more significant structural fullness than lower-concentration lip fillers can provide.
• Volume Loss Correction: Tailored for patients experiencing noticeable age-related volume depletion in the perioral area.

Advanced Structural Technology

The formulation relies on specialized polymer engineering to ensure natural movement and durability:

• IPN-Like Technology™: Combines two interlocked hyaluronic acid polymer networks. This design enhances cohesivity and elasticity, helping the gel resist repetitive deformation caused by constant lip movement and support a lasting shape.
• BI-FLEX® Rheological Profile: Provides a precise balance between flexibility and cohesivity. The resulting gel is soft enough to move naturally with facial expressions, yet maintains sufficient internal structure to resist migration.

Clinical Utility & Delivery

• Integrated Comfort: The formulation contains mannitol, a free radical scavenger that may help reduce oxidative degradation of hyaluronic acid and support product longevity. Co-formulated 0.3% lidocaine reduces injection discomfort in the highly sensitive lip treatment area without requiring a separate anesthetic step.

Global Recognition: For practitioners evaluating whether STYLAGE® is a good filler, the product’s concentrated HA formulation, IPN-Like Technology™, BI-FLEX® rheology, and CE-marked manufacturing standards make it a recognized choice in aesthetic medicine.

• Lip volume enhancement and contour definition
• Correction of age-related volume depletion affecting lip fullness and projection
• Vermillion border definition and philtrum column enhancement
• Perioral line correction and lip contour refinement

The LIPS PLUS concentration is particularly well-suited to pronounced augmentation and significant volume-loss correction. Patient selection should account for lip tissue characteristics, skin type, and desired augmentation outcome. STYLAGE® LIPS PLUS BI-FLEX® with Lidocaine is intended exclusively for licensed aesthetic medicine professionals; self-administration is contraindicated.

Cross-linked hyaluronic acid integrates into lip tissue and attracts water molecules, producing an immediate volumizing and defining effect that enhances lip contour, shape, and fullness. IPN-Like Technology™ supports this through two interlocked polymer networks that enhance gel cohesivity and resist deformation from constant lip movement, contributing to lasting volume retention and shape definition.

The BI-FLEX® gel structure allows the filler to integrate smoothly within lip tissue, supporting natural-feeling results while minimizing the risk of irregular contours or migration. Co-formulated 0.3% lidocaine provides localized anesthetic action during injection, improving patient comfort in the sensitive treatment area in the lips.

Like all hyaluronic acid-based injectable dermal fillers, STYLAGE® LIPS PLUS BI-FLEX® with Lidocaine is fully reversible through hyaluronidase administration if correction or reversal becomes necessary.

STYLAGE® LIPS PLUS BI-FLEX® with Lidocaine injection should only be performed by trained medical professionals experienced in lip anatomy and soft-tissue augmentation. Common injection sites include the lip body, vermillion border, and philtrum columns, with depth and technique determined by the practitioner based on individual treatment goals.

• Anesthetic Flexibility: Topical anesthesia may still be applied at the practitioner’s discretion, as co-formulated lidocaine at 0.3% does not preclude additional anesthetic measures.
• Post-Treatment Restrictions: Following treatment, patients should avoid excessive sun exposure until redness and swelling resolve, and minimize unnecessary pressure on treated areas.
• Injection Site Response: Bruising at the injection site may occur and typically resolves within a few days.

Post-Treatment Side Effects & Adverse Events

• Common Reactions: Post-treatment reactions in the lip treatment area include swelling, redness, tenderness, and bruising. These effects are generally mild and localized, typically resolving within a few days, though recovery may vary depending on skin type and injection depth.
• Serious Adverse Events: Although uncommon, serious complications may occur with all injectable dermal fillers, including vascular occlusion, skin necrosis, and visual disturbance. Practitioners must follow established emergency management protocols and be familiar with the appropriate use of hyaluronidase.
• Pre-Treatment Screening: Patients should be screened for hypersensitivity to hyaluronic acid, allergy to amide-type local anesthetics, and active infection at the treatment site before starting the procedure.

Refer to the complete Instructions for Use (IFU) for comprehensive safety guidance.

STYLAGE® LIPS PLUS BI-FLEX® with Lidocaine is manufactured in France by Laboratories VIVACY and is CE-marked for professional aesthetic use within applicable European markets. Current U.S. FDA approval status and regional regulatory requirements should be independently verified before procurement or clinical use. Practitioners evaluating sourcing options should confirm distributor authenticity and applicable regulatory compliance when buying online. Practitioners who wish to buy dermal fillers or buy STYLAGE® may contact Maylips support team for sourcing information and documentation support.

For sourcing guidance, contact Maylips support team.

Regulatory information current as of mid 2026. Practitioners should confirm local regulatory status before sourcing.